An Overview of Migraine Without Aura

Also Known as the Common Migraine

Table of Contents
View All
Table of Contents

Migraine without aura is one of two major types of migraines, and 75% of those who have the condition experience this particular kind. Also known as "common" migraine, people who have migraine without aura don’t get the visual or sensory warning signs, known as migraine prodrome, that are classic to the other type—migraine with aura.

migraine without aura

Verywell / Emily Roberts


The symptoms you experience during migraine without aura may not be exactly the same as someone else. Likewise, they can differ from episode to episode.

Symptoms of migraine without aura include:

  • Pain on one side of head
  • Pulsing or throbbing pain
  • Sensitivity to light (photophobia)
  • Sensitivity to sound (phonophobia)
  • Nausea and/or vomiting
  • Pain or discomfort that is made worse by physical activity


Scientists used to believe that migraines were caused by dilation of blood vessels in the brain. Now they believe that the release of substances, such as calcitonin gene-related peptide (CGRP), from activated trigeminal nerves will trigger the migraine pain.

Migraines are also associated with estrogen, which explains why migraines are more prevalent in women. Typically, higher estrogen levels will prevent migraine headaches, whereas lower estrogen levels can trigger them. But it may be more the fluctuation or change in estrogen that triggers a migraine, not simply the fact that the level is low.

Estrogen is also associated with increased levels of serotonin in the brain, so a decline in estrogen may be accompanied by a decrease in serotonin. Researchers believe that fluctuations in serotonin levels play a role in triggering migraines.

According to the American Migraine Foundation, migraine disease is often hereditary; if one or both of your parents have it, you have a 50% to 75% chance of getting it too.

Menstrual Migraine

The relationship between migraines and women's menstrual cycle is not fully understood, but data do show more than half of migraines in women occur right before, during, or after a woman has her period. This suggests a link but, notably, only a small fraction of women who have migraine around their period only have migraine at this time. Most have migraine headaches at other times of the month as well.


The diagnosis of migraine without aura is based on symptoms and history that you report to your healthcare provider.

According to the third edition of the International Classification of Headache Disorders, a diagnosis of migraine without aura can only be made when a person has at least five attacks meeting the following criteria:

  • Headaches that last four to 72 hours
  • Headaches that have at least two of the following characteristics: Unilateral (one-sided); a throbbing sensation, such as rapid beating or pulsation; pain that is of moderate to severe intensity
  • Migraine pain worsened by regular physical activity (i.e., walking, climbing stairs)
  • Nausea and/or vomiting
  • Photophobia and phonophobia
  • Headache that cannot be attributed to another disorder

Take Notes

Keeping a journal to record your symptoms and the frequency of your migraines is useful for helping your healthcare provider make a diagnosis.

Your healthcare provider may also have you answer the POUND mnemonic and ID migraine questionnaire, which can help clinch the diagnosis.

There is no blood test or imaging test that can confirm the diagnosis, although these may be used to rule out other possible causes, such as a tumor, stroke, brain bleed, and other neurological conditions.



Historically, migraine treatment was limited to medications that were approved for other uses but were found to be beneficial for helping migraine symptoms. Within the last few years, however, the Food and Drug Administration (FDA) has approved a newer class of medications that are specifically approved for the treatment of migraine.

CGRP inhibitors help prevent or treat acute migraine by blocking CGRP from attaching to receptors in the brain. Options in this class, broken down by use, include:

  • Migraine prevention: Vyepti (eptinezumab-jjmr), Emgality (galcanezumab-gnlm), Aimovig (erenumab-aooe), Ajovy (fremanezumab-vfrm), Nurtec ODT (rimegepant)
  • Acute migraine: Ubrelvy (ubrogepant), Nurtec ODT (rimegepant), Zavzpret (zavegepant)

First and Only CGRP for Acute and Preventive Treatment

In May 2021 the FDA expanded approval for Nurtec ODT (rimegepant) to include migraine treatment, making it the first medication approved to both treat and prevent migraines. Nurtec ODT comes in pill form and is taken once every other day for prevention and as needed for acute migraine.

Numerous other types of medications can be used to prevent migraines or treat them once they've taken hold.

Medication classes shown to help treat acute migraine include:

  • Non-steroidal anti-inflammatories (NSAIDs), such as (Advil) ibuprofen or (Aleve) naproxen sodium
  • Triptans, including Imitrex (sumatriptan) and Zomig (zolmitriptan)
  • Antiemetics (anti-nausea medications)
  • Dihydroergotamines, including Migranal (D.H.E.)
  • Dexamethasone
  • Nerve blocks

Medication classes shown to help prevent migraine include:

  • Antihypertensives (blood pressure lowering agents), such as metoprolol, propranolol, and timolol
  • Antidepressants, such as Elavil (amitriptyline) and Effexor (venlafaxine)
  • Anticonvulsants: These include valproate products, divalproex sodium, sodium valproate, and Topamax (topiramate)
  • Botox (onabotulinumtoxin A), an injectable muscle paralytic drug used for chronic migraine prevention

People who suffer from migraines without aura are more likely than those who have other headache disorders to develop a medication-overuse (rebound) headache. Be sure to take a migraine drug exactly as directed.

Non-Medication Options

Beyond medications, there are also several neuromodulation devices that have been approved by the FDA for treatment of migraine without aura. These include:

  • Transcutaneous supraorbital neurostimulator (tSNS): Also called the Cefaly device, it uses electricity to activate forehead nerves. The signal goes into the brain, slowly turning down headache pathways over time.
  • Single-pulse transcranial magnetic stimulator (springTMS, sTMS): This magnet is placed on the back of the head and turned on for a split-second pulse.
  • Non-invasive vagal nerve stimulator (nVNS): Called gammaCore, this device is placed on the neck over a gel and turned on to electrically stimulate the vagus nerve.
  • Remote electrical neuromodulation (REN): REN stimulates small nerves in the upper arm. The message from the arm is received by a brainstem pain regulation center that can inhibit pain signals by releasing neurotransmitters, resulting in significant pain relief which can end the migraine attack. Currently, the only REN device approved for use by the FDA is Nerivio, which is secured to the arm using an armband.

Alternative treatments—including acupuncture, massage, and certain herbs and supplements—may also be helpful for preventing and treating migraines. Furthermore, many find lifestyle measures, such as meditation, exercising, avoiding certain foods, and getting enough sleep, to be an important part of their overall care.


Migraine without aura can be disabling, causing you to miss work and social events, and making it difficult to care for your loved ones. Because migraines are so prevalent, numerous online and in-person support groups are available for patients as well as their families and caregivers. Your healthcare practitioner can help you find support groups.

A Word From Verywell

Migraine without aura can be a debilitating neurological disorder, but fortunately, a variety of treatments are currently available that people who suffer from this condition can try. If you think you suffer from migraines, make sure to see a healthcare provider for a proper diagnosis and treatment plan.

10 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Migraine Research Foundation. About Migraine.

  2. American Migraine Foundation. Migraine Without Aura.

  3. Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018 Feb;17(2):174-182. doi: 10.1016/S1474-4422(17)30435-0.

  4. U.S. Department of Health and Human Services, Office on Women's Health. Migraine.

  5. American Migraine Foundation. The Genetics of Migraine.

  6. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202.

  7. Nurtec ODT (rimegepant). Full Prescribing Information.

  8. Allen SM, Mookadam F, Cha SS, et al. Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort Study. J Am Board Fam Med. 2018 Mar-Apr;31(2):211-218. doi: 10.3122/jabfm.2018.02.170188.

  9. American Migraine Foundation. Spotlight On: Neuromodulation Devices for Headache.

  10. Hershey AD, Lin T, Gruper Y, et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache. 2021 Feb;61(2):310-317. doi: 10.1111/head.14042.

Additional Reading
  • Stephen D. Silberstein MD, Michael J. Marmura MD. Acute Migraine Treatment. Headache, 20 January 2015. doi: 10.1111/head.12504 

By Colleen Doherty, MD
 Colleen Doherty, MD, is a board-certified internist living with multiple sclerosis.